Tramadol Versus Fentanyl for Post-Operative Analgesia in Newborn Infants
This study has been completed.
Sponsor:
Federal University of São Paulo
Collaborator:
Albert B. Sabin Vaccine Institute
Information provided by:
Federal University of São Paulo
ClinicalTrials.gov Identifier:
NCT00713726
First received: July 9, 2008
Last updated: July 10, 2008
Last verified: July 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
In newborn infants submitted to surgical procedures, tramadol may provide an effective analgesia and decrease the time on mechanical ventilation support and the time to achieve full enteral feeding.
| Condition | Intervention | Phase |
|---|---|---|
|
Pain Neonatal Infections Analgesia |
Drug: FentanyL Drug: Tramadol |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Post-Operatory Analgesia in Newborn Infants: a Comparative Study of Fentanyl Versus Tramadol |
Resource links provided by NLM:
Further study details as provided by Federal University of São Paulo:
Primary Outcome Measures:
- Pain assessment wuth CRIES and NFCS pain scales during the first 72 hours after surgical procedure [ Time Frame: Every 2-4h during the first 72 hours after surgical procedure ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Time between surgical procedure and successful extubation [ Time Frame: Hospital stay ] [ Designated as safety issue: Yes ]
- Time between surgical procedure and achievement of 100 mL/kg of enteral feeding [ Time Frame: hospital stay ] [ Designated as safety issue: Yes ]
| Enrollment: | 160 |
| Study Start Date: | January 2006 |
| Study Completion Date: | July 2008 |
| Primary Completion Date: | July 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: F
Patients that received continued infusion of fentanyl at a steady dose for the first 48 hours and, then, doses were gradually decreases until stop
|
Drug: FentanyL
Fentanyl: 1 µg/kg/h for preterm infants and 2 µg/kg/h for term infants for 48 hours and than gradually decrease until interruption of the drug.
|
|
Experimental: T
Patients that received continued infusion of tramadol at a steady dose for the first 48 hours and, then, doses were gradually decreases until stop
|
Drug: Tramadol
Tramadol: 0.1 mg/kg/h for preterm infants and 0.2 mg/kg/h for term infants for 48 hours and than gradually decrease until interruption of the drug.
|
Eligibility| Ages Eligible for Study: | up to 28 Days |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Infant 0-28 days of life with indication of large or medium surgical procedure (definition according to the American College of Cardiology, American Heart Association - 2002)
Exclusion Criteria:
- Death or hospital discharge until 72 hours after surgical procedure
- New surgery until 72 hours after the studied surgical procedure
- Proved bacterial infection before surgery
- Ambiguous genitalia
- Chromosomal syndromes
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00713726
Locations
| Brazil | |
| Albert Sabin Hospital | |
| Fortaleza, Ceará, Brazil, 60.410.790 | |
Sponsors and Collaborators
Federal University of São Paulo
Albert B. Sabin Vaccine Institute
Investigators
| Study Director: | Ruth Guinsburg, MD | Federal University of São Paulo |
| Principal Investigator: | Ana Julia C Alencar | Federal university of são Paulo and Albert Sabin Hospital |
More Information
No publications provided by Federal University of São Paulo
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Ruth Guinsburg, MD, Federal University of São Paulo |
| ClinicalTrials.gov Identifier: | NCT00713726 History of Changes |
| Other Study ID Numbers: | 1386/06 |
| Study First Received: | July 9, 2008 |
| Last Updated: | July 10, 2008 |
| Health Authority: | Brazil: National Committee of Ethics in Research |
Keywords provided by Federal University of São Paulo:
|
Pain Analgesia Newborn Infant Opioids |
Side-effects Intensive care Postoperative |
Additional relevant MeSH terms:
|
Fentanyl Tramadol Adjuvants, Anesthesia Central Nervous System Agents Therapeutic Uses Pharmacologic Actions Narcotics Central Nervous System Depressants |
Physiological Effects of Drugs Analgesics Sensory System Agents Peripheral Nervous System Agents Anesthetics, Intravenous Anesthetics, General Anesthetics Analgesics, Opioid |
ClinicalTrials.gov processed this record on May 23, 2013